Q3 2024 Profound Medical Corp Earnings Call Transcript
Key Points
- Profound Medical Corp (PROF) reported a 64% increase in third-quarter revenue compared to the same period in 2023, reaching $2.83 million.
- The company achieved a gross margin of 64% in Q3 2024, up from 61% in Q3 2023, indicating improved profitability.
- The Tulsa procedure is gaining traction as a mainstream treatment option for prostate disease, with strong endorsements from leading physicians.
- CMS has elevated the Tulsa procedure to urology APC level seven, offering higher reimbursement rates than other prostate treatments, which is expected to drive adoption.
- Profound Medical Corp (PROF) is transitioning to a more traditional medical device business model, which is anticipated to deliver high margins and be economically attractive to users.
- Profound Medical Corp (PROF) recorded a net loss of $9.4 million in Q3 2024, compared to a net loss of $5.6 million in the same period in 2023.
- Operating expenses increased by 42% year-over-year, driven by higher R&D, G&A, and sales and distribution costs.
- The company faces challenges in reaching its goal of 75 installed systems by year-end due to the transition from a cash pay model to a reimbursement-based model.
- There is uncertainty in the mix between capital and recurring revenue in the near term, making it difficult to predict financial outcomes.
- Profound Medical Corp (PROF) needs to expand its sales team significantly to capitalize on the growing pipeline and demand for the Tulsa procedure.
Good day. And thank you for standing by.
Welcome to the Profound Medical Third Quarter, 2024 financial results conference call.
At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session to ask a question during the session. You will need to press star 11 on your telephone. You will then hear an automated message advising your hand is raised to withdraw your question. Please press star 11 again.
Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Stephen Kilmer Investor relations. Please go ahead.
Thank you. Good afternoon. Everyone. Let me start by pointing out that this conference call will include forward-looking statements within the meaning of applicable securities laws in the United States and Canada.
All forward-looking statements are based on profound current beliefs, assumptions and expectations and
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
